Unknown NA INTERVENTIONAL 1-arm NCT05160831

Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Knee Osteoarthritis

Sponsor: Southwest Hospital, China

Interventions Human umbilical cord mesenchymal stem cells

Updated 4 times since 2022 Last updated: Dec 6, 2021 Started: Jan 20, 2022 Primary completion: Jan 20, 2023 Completion: Jan 20, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Knee Osteoarthritis and is currently ongoing. Southwest Hospital, China leads this study, which shows 4 recorded versions since 2022 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Not Yet Recruiting → Unknown Status
Jan 2022 — Feb 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Southwest Hospital, China

Data source: Southwest Hospital, China

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.